Vancouver, British Columbia – June 24, 2025 – P2P Group Ltd. (CSE: PPB / FSE:3QG US: PPBGF) is pleased to announce that a major New Zealand-based disability care provider is commencing an on-premise trial of the Inturai platform.

The trial represents the first in-market deployment of Inturai’s real-time sensing and activity recognition system in the disability care sector. It will focus on delivering enhanced safety, privacy and quality of life outcomes through Inturai’s AI-driven, hardware-free monitoring solution.

This initial phase includes live testing in test and residential environments, aiming to validate use cases such as event detection, activity mapping and responsive care alerting, without the use of invasive cameras or wearable devices to maintain client dignity.

“This is a high-trust sector where dignity and safety must be delivered together,”said Ed Clarke, CEO of P2P Group. “We are proud to see our platform entering thetrial stage with one of New Zealand’s leading care providers. It’s a significant milestone in expanding our health sector impact.”

Trial results will be used to inform planning for broader rollout across the provider’snational operations, pending successful outcomes and stakeholder engagement.Updates will be provided should they become material.

‍

*Source: custommarketinsights.com